LY2216684

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for LY2216684, covering 2018-04-24 to 2019-07-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2216684 and Theophylline in Healthy Subjects [Phase 1]